Dr. Harris is President of CareAllies, a Cigna Company and a Fellow with the Harvard Kennedy School Healthcare Policy Program. CareAllies is an innovative population health management services company focused on helping physician groups and delivery systems navigate the transition to value-based care. Dr. Harris joined Cigna in 2015 as Senior Vice President of Strategic Operations to optimize the company’s approach to multi-year planning and internal investments and to accelerate the company’s delivery of value-based solutions in local markets. He launched and became President of CareAllies in 2016.
Prior to Cigna, Dr. Harris served as the Associate Director for Health in the White House Office of Management and Budget (OMB). As the federal government’s chief health care budget official, he oversaw $1 trillion in spending and policy for a range of coverage programs, including Medicare, Medicaid, Marketplaces, and the CMS Innovation Center. Dr. Harris led OMB’s engagement and oversight of agencies on initiatives as diverse as developing new CMS Medicare ACO and bundled payment models, replacing the SGR with MACRA, and launching the President’s precision medicine initiative.
During his time as the chief executive of the then $11 billion Medicaid program in Massachusetts, Dr. Harris led the development of a primary care-centered ACO program and built value-based payment into the country’s first Medicare-Medicaid duals demonstration. He has also advised providers and investors on innovative approaches to navigating and supporting the transition to value-based payment and population health.
Dr. Harris trained in internal medicine and primary care at Harvard Medical School’s Brigham & Women’s Hospital, and he worked as a hospitalist at Cambridge Health Alliance. He graduated with a bachelor’s degree in Health Policy & Medical Ethics from Duke University, and he holds a Master of Science degree from Oxford University, where he studied as a Rhodes Scholar. He is also a graduate of the Health Care Management MBA Program at the Wharton School of Business and the School of Medicine at University of Pennsylvania.